|
1.IntroductionOptical techniques such as confocal and two-photon fluorescence microscopy yield micron-resolution images of tissue sections down to depths of a few hundred microns, beyond which multiple light scattering causes significant blurring. For many biomedical applications, particularly in vivo, it is often necessary to compromise on the spatial resolution in order to achieve larger fluorescence imaging depths over large (cm-scale) field of view (FOV). One such application is fluorescence-guided cancer surgery, using red/near-infrared (NIR) molecular probes.1,2 In the last decade, this approach has been most highly developed for brain tumor surgery using the optical contrast provided by protoporphyrin IX (PpIX) that is endogenously synthesized in tumor cells following administration of the pro-drug -aminolevulinic acid (ALA).3–7 Significant improvement in survival has been demonstrated in patients with high-grade glioma,7,8 even using qualitative visual assessment of the PpIX fluorescence to identify residual tumor after white-light resection, and we have previously reported on preclinical and clinical techniques to quantify the absolute PpIX concentration in the tissue at the time of surgery, using either a point probe spectroscopy technique6,9–16 or wide-field quantitative imaging of the tissue surface.5,17–21 In this and other clinical applications, the ability to detect fluorescent tumor foci lying significantly below the surface of the surgical cavity could further increase the completeness of tumor resection to impact survival and also improve patient safety by minimizing the need for blind exploratory resection.8,22–24 This is the focus of the work reported here. There is considerable ongoing preclinical development of novel high-specificity, molecularly targeted NIR fluorescent imaging agents that can eventually be translated to clinical use for surgical guidance.25–27 The use of NIR fluorophores allows detection of fluorescence from significant depths in tissue due to the relatively low optical absorption above the main hemoglobin absorption range and the reduced scattering at these wavelengths. However, since most tissues are still highly turbid () at these wavelengths, the rapid diffusion of the light degrades the attainable spatial resolution. In addition, the concentration and depth of the fluorescent sources are difficult to separate: e.g., the same detected signal can be generated from a low fluorophore concentration close to the tissue surface or a high concentration at depth. This is addressed here by introducing a topographic technique to estimate the fluorophore depth. The technique has been specifically developed for ALA-PpIX fluorescence-guided brain cancer surgery, but the concept can be applied to other fluorophores and tumor sites with suitable adjustment of the wavelengths and corresponding tissue optical properties. Over the last two decades, several approaches have been developed to localize fluorescent sources in vivo, especially for whole-body preclinical imaging using small animal models (see Ref. 28 for a review). These include diffuse fluorescence tomographic imaging by scanning over multiple source-detector positions, for example by using photon time-of-flight methods implemented in either the time or frequency domain.29–32 Other techniques rely on time-resolved single-point detection to retrieve the source depth based on the average photon time of flight.33 However, data acquisition for these techniques can be time consuming, typically requires expensive equipment, and is very sensitive to small instrument misalignments, making them very difficult to implement for routine surgical guidance in critical sites such as the brain. In neurosurgery, the introduction of novel technologies complementing the standard of care (i.e., neurosurgical microscope and neuronavigation unit) must be minimally disruptive to the surgeon workflow. As a result, instrumentation with a minimal footprint is required that can provide surgeons with optical information within time frames compatible with the flow of a surgical procedure (i.e., within a few seconds). Here, we are presenting such a technique, namely a multispectral, dual wavelength, self-normalized technique that can be seamlessly integrated onto a commercial surgical microscope to provide topographic maps of fluorescent sources down to several millimeters in tissue with accuracy and precision. By topographic imaging, here we mean that the depth of the fluorescent structure that is closest to the accessible tissue surface (e.g., the resection cavity) is determined. This is distinct from fluorescence tomography where the goal is to reconstruct the full three-dimensional fluorophore distribution in the tissue. We have previously reported two complementary methods of fluorescence topography, as demonstrated using PpIX as the fluorophore. Initially, multiple excitation wavelengths in the visible range were used, with a common long-wavelength detection band ().21 The effective optical sampling depth (which depends on the wavelength-dependent tissue optical properties) of the fluorophore then primarily depended on the excitation wavelengths. By ordering the resulting fluorescent images according to the increasing penetration depth of the excitation light and applying a threshold value to the signals, a tomographic two-dimensional depth profile was generated that was experimentally shown to represent the top surface of the subsurface fluorophore distribution. The depth accuracy in brain was up to a depth of about 3 mm for PpIX. In the second method,19 the longest excitation wavelength of PpIX (635 nm) was used and hyperspectral fluorescence images were taken at the tissue surface. The wavelength-dependent distortion of the detected fluorescent light was shown to correlate with the effective depth (up to ) of the fluorophore and thereby suggested that a tomographic subsurface image could be produced. The present work develops this second approach further by demonstrating that a simple ratiometric method can be used to actually retrieve the fluorophore depth. The fact that the technique is directly integrated onto a neurosurgical microscope and that image acquisition and processing can be achieved within a few seconds should facilitate its translation to clinical use. In brief, the technique relies on the observation that the logarithm of the ratio, , of the detected fluorescence signal at the tissue surface at two wavelengths varies linearly with the depth, , of a fluorescent point source in an optically turbid medium, as experimentally demonstrated by Swartling et al.34 Our group previously derived analytic solutions to the diffusion equation for this situation in order to better understand the physical basis of this relationship.19 Thus, we showed that for a point-like fluorescent inclusion where the tissue optical properties at wavelength, , are characterized by the diffusion coefficient and the effective penetration depth both of which are functions of the absorption coefficient, , and the reduced scattering coefficient, .35Equation (1) is of the general form so that we hypothesize that dual-wavelength fluorescence ratiometric imaging can be used for topographic mapping of the subsurface fluorophore depth from the expressionThus, the hypothesis we are making here is that the depth of fluorescent sources can be estimated even in cases where the distribution is not point-like, as explained and motivated in Ref. 19. Clearly, the use of Eq. (5) to retrieve the depth using a wide-field imaging system for every image pixel requires making reliable estimates for and . In the present work, we are introducing a normalization technique to make the depth-retrieval independent of the intercept and where tissue attenuation properties are used to estimate a value for the slope parameter by applying either light transport models (requiring the tissue optical properties to be known a priori) or non-model-based techniques using measured diffuse reflectance data. It is demonstrated that depth estimates can be obtained with accuracy using Eq. (1) when the optical properties are known a priori. Similar depth accuracy can be achieved using a non-model-based approach, but only for a restricted subset of tissue absorption and scattering values. The approach is also limited to high-contrast fluorescent targets, i.e., where the tissue autofluorescence is low relative to the exogenous fluorophore. As we have previously demonstrated, this condition is realized for ALA-PpIX fluorescence for a range of brain tumors, including high-grade glioma and meningioma.13 2.Materials and Methods2.1.Imaging SystemFigure 1 shows a schematic of the hyperspectral imaging system, which is attached to a free optical port on a commercial neurosurgical microscope (Carl Zeiss Meditec). The microscope has optics allowing zoom and FOV adjustment and is equipped with a variable-intensity bright-field tungsten-halogen lamp (white light) for surface structural imaging. The design of the detection system has been described elsewhere.5 In brief, it comprises a liquid crystal tunable filter (LCTF-VariSpec, CRi), a 650-nm long-pass filter (Chroma), and a charge-coupled device camera (PixelFlyUSB, PCO). The detection subassembly is attached to the side port using a custom optical adapter (TrueTex), ensuring that the magnification and FOV of the fluorescent images are consistent with what the surgeon views through the microscope eyepieces. A long-pass filter ( OD attenuation above 635 nm) blocks most of the excitation light, while the liquid crystal tunable filter then selects the fluorescence detection wavelength in 5 nm increments from 650 to 720 nm, allowing the acquisition of 14 fluorescence images at different wavelengths. For fluorescence excitation, the light from a 635-nm laser diode (Intense Co) with maximum power is guided through a collimator and a 635 band-pass filter (Chroma) to eliminate out-of-peak background light. At each fluorescence detection wavelength, a diffuse reflectance image is also acquired with the long-pass filter removed to allow the acquisition of 14 reflectance images at different wavelengths. 2.2.Tissue-Simulating Phantom StudiesA phantom (Fig. 1) was designed to simulate a discrete fluorescent tumor surrounded by tissue with minimal autofluorescence. It comprised a 20-cm diameter black plastic cylindrical container filled with intralipid (Patterson Veterinary Supply) for light scattering and bovine methemoglobin (Sigma Aldrich) for absorption, each at different concentrations to provide a range of optical properties consistent with normal brain tissue at 700 nm:13 (1 part intralipid 20% to 10 parts water) for the first two phantoms and (1.36 parts intralipid 20% to 10 parts water) for the third phantom; ( mHb) for the first phantom and () for the second and third phantoms: see Table 1. Table 1Optical properties (at 670 nm in cm−1) used for the experimental studies and single-point depth recovery results (all in mm) associated with the three different techniques.
A 1-cm diameter, 1-cm high transparent hollow inclusion was placed at the center of the larger container described above. The smaller inclusion was filled with a solution composed of of the fluorophore Alexa Fluor 647 (Life Technologies) mixed with the same intralipid/methemoglobin solutions used for the turbid medium material surrounding the inclusion. The subsurface depth, , to the top of the inclusion (from the surface of the liquid) was increased in 1 mm steps until the fluorescence signal was indistinguishable from the nonspecific background (at in all cases) of the residual excitation light bleed through and intrinsic fluorescence of the intralipid. For repeatability and to minimize the impact of time on tissue phantom properties, the experiments in this work were conducted with a dye (Alexa Fluor 647) having more favorable biochemical properties than PpIX (e.g., quantum yield and photostability) but having similar spectral features when excited with red light. The incident fluorescence excitation power density was over a circular FOV of for a distance of 20 cm between the microscope condenser lens and the phantom surface. The total image acquisition time (14 fluorescence images and 14 reflectance images) was in all cases . In order to account for the instrument response function of the imaging system, each reflectance image was normalized to the corresponding image taken using a Spectralon diffuse reflectance standard (Labsphere). 2.3.Monte Carlo SimulationsMonte Carlo simulations were performed using a plug-in developed for the GEANT4/GAMOS radiation transport model.36 The input optical properties included those used in the phantom measurements, and additional absorption-scattering combinations were included to verify that the results were valid over a broader range of optical properties (Table 2). Each simulation launched photons in a 20-cm diameter uniform beam for each inclusion depth and combination of optical properties. The quantum yield of PpIX was set at 0.004, while the diffuse reflectance measurements spanned 630 to 720 nm in 10 nm steps. The light intensity at the surface was recorded for both the fluorescence emission and the white-light diffuse reflectance. The simulated source of fluorescence was a 5-mm thick slab, where the depth from the top of the inclusion to the surface ranged from 0 to 10 mm in 1 mm steps. Table 2Optical properties (at 670 nm in cm−1) used for the Monte Carlo light transport studies and single-point depth recovery results (all in mm) associated with the three different techniques.
3.Results3.1.Single-Point Analysis: Comparison with Experimental DataThe average fluorescence spectra, , and diffuse reflectance spectra, , were evaluated over a region of interest close to the middle of the inclusion, as indicated by the circle in Fig. 1(b). A MATLAB® script (MathWorks) was developed to calculate the corresponding dual-wavelength fluorescence ratios (DWFR) for all wavelength pairs and for each inclusion depth, to 6 mm, within the region of interest, where the indices and are running from 1 to 14, i.e., over all spectral bands (wavelengths) detected with the imaging system. The DWFR at each depth, , was then divided by the DWRF value at . Using Eq. (4) and the mathematical identity , it is seen that normalizing by the image accomplishes three things: (1) it isolates the depth-dependent part of the fluorescence ratio independent of the emission spectrum of the dye, (2) it corrects for the wavelength-dependent system response, and (3) it removes the dependence on the parameter found in Eq. (4):Then, under the hypothesis that Eq. (1) captures the essential light transport processes, the fluorophore depth can be estimated by dividing the logarithm of the normalized DWFR in Eq. (7) by , which is computed as described below. However, depth retrieval based on Eq. (7) requires that a fluorescence ratio measurement be made for , which amounts to making a reference measurement of the fluorophore of interest (AF 647 in the present study). In practice, this could be achieved (e.g., during a fluorescence-guided surgery procedure) by using a fluorescence ratio measurement made on cancer tissue located directly on the surface of the surgical cavity. As a result of Eq. (7), it is found that depth retrieval relies on the ability to: (1) acquire zero-depth data (for calibration purposes through normalization) corresponding to a reference measurement made with no intervening tissue between the imaging system and a standard Alexa Fluor 647 fluorescence source and (2) compute . Table 3 summarizes the three techniques investigated to compute , including the mathematical expressions used and the required input parameters. Each technique is now briefly described: Technique 1 (diffusion equation solution) is diffusion model based and requires both tissue absorption and reduced scattering coefficients to be known a priori, with then being directly computed using Eq. (1). The other two techniques were designed to estimate with a minimum number of input parameters. For Technique 3 (non-model based), since diffusion modeling19 and experiments34,37 have shown that is directly related to factors responsible for the differential tissue attenuation between and , we used empirical combinations of the measured diffuse reflectance values, in the bands around and as a surrogate for tissue attenuation. Several mathematical expressions were considered (e.g., , for a large range of values), but the simple expression shown in Table 3 gave the most accurate predictions compared to the experimental phantom results and the Monte Carlo simulations. Technique 2 is a hybrid between Techniques 1 and 3. It is partly model based, since it does not require prior knowledge of the tissue absorption coefficient but does require the reduced scattering coefficient value at 700 nm as an input parameter. As with Technique 3, the expression shown in Table 3 for Technique 2 was found through an optimization process. In cases where the calculation of the parameter requires the optical properties as input values, the known optical properties of the tissue phantom were used (see Sec. 2.2). Table 3Main characteristics of the three different techniques used to recover depth.
For conciseness, the results for the representative wavelength pair 670 and 720 nm are presented here. However, Eq. (7) and fluorescence ratio measurements were used to predict depth using other wavelength pairs (one wavelength pair at the time and not by using the information of several wavelength pairs simultaneously) since the imaging system is acquiring spectroscopic data for every camera pixel. The results for other wavelength pairs are discussed in the Discussion section. Figures 2 and 3 show the results (based on the three techniques in Table 3) for two different sets of optical properties and where depth predictions are made based on the experimental data for a fluorescent inclusion. In Figs. 2(a) and 3(a), the points associated with the label “Experimental” are the DWFR values computed with the experimental data. Figures 2(b) and 3(b) show the graphs of the predicted depths () computed using Eq. (7) for all three techniques as a function of true depth values (), i.e., the actual distance between the top of the fluorescent inclusion and the surface of the bulk medium in the experimental phantom (Fig. 1). On those graphs, the straight line is plotted for reference and simply represents the real depth values. Figures 2(c) and 2(d) and 3(c) and (d) present the experimental errors (absolute and relative) associated with depth predictions when compared with the real depths. Table 1 shows the corresponding differences between the calculated and true depths (mean and maximum errors) for all sets of optical properties and all three techniques. 3.2.Wide-Field Topographic Maps: Comparison with Experimental DataThe same experimental dataset as used in Sec. 3.1 was used to retrieve the fluorophore depth across the full FOV of the camera using fluorescence ratio measurements for the wavelength pair 670 and 720 nm. A topographic map was produced using Eq. (7) to predict local depth values using the three techniques in Table 3. The reference fluorescence ratio measurement used in the equation was the fluorescence ratio measured directly at the center of the fluorescence images. For the 670 and 720-nm wavelength pair image, pixels were binned to increase the signal to noise such that the spatial resolution was , and pixels were retained only above a fluorescence intensity threshold corresponding to of the highest intensity of the 670-nm fluorescence image. In fact, pixels below this threshold did not lead to physically meaningful depth values and the corresponding raw spectra typically did not show the spectral features of Alexa Fluor 647. Pixels with insufficient signal to noise or non dye-specific signals are represented with the color black in Fig. 4. The figure only shows representative results for and , but similar images were obtained for the other optical properties considered. 3.3.Single-Point Analysis: Comparison with Monte Carlo DataIn order to validate the experimental results and extend the range of optical properties considered, detailed numerical simulations were carried out over a range of tissue properties relevant for brain imaging. For conciseness, in Figs. 5 and 6 and in Table 2, we show only the results for the representative wavelength pair 670 nm and 720 nm. Table 2 shows recovered depth accuracy figures (mean, standard deviation, and maximum and minimum errors) for all sets of optical properties considered using the techniques in Table 3. The predictions (fluorescence ratio and recovered depth) made with Techniques 1 and 2 verify the Monte Carlo simulated data for all sets of optical properties. However, we find that Technique 3 is uniquely suited for optical properties having the lowest values of scattering. 4.DiscussionThe Monte Carlo simulations (in single-point analysis mode only) show that, for optical properties consistent with brain tissue, Technique 1 (tissue input parameters to compute : absorption and reduced scattering) and Technique 2 (input tissue parameter to compute : reduced scattering only) are both able to accurately recover the fluorophore depth up to 5 mm with an average error of , while the depth errors with Technique 3 (no tissue input parameters to compute ) were on average . The single-point experimental data were consistent with these findings. Although experimental and Monte Carlo data were acquired for multiple wavelengths, the fluorescence ratio results were only presented above for the wavelength pair 670 and 720 nm. However, detailed analyses for all possible wavelength pairs (considered one pair at the time for topographic depth recovery) led to similar conclusions, while, in general, using both wavelengths above 700 nm resulted in larger errors, likely due to the smaller spectroscopic changes in hemoglobin absorption in that region. As might be expected, maximizing and achieving the best agreement with the models were obtained using wavelength pairs associated with the largest relative changes in tissue optical properties. Simulations for a slab rather than a finite-size inclusion were presented here in order to evaluate the technique using datasets where the main variable is depth and not the actual geometry of the fluorescent source. However, Monte Carlo simulations were also performed for a geometry identical to that used for the experimental work, i.e., a cylindrical inclusion. Although the results for a cylindrical inclusion are not presented here for conciseness, they have led to single-point analysis results essentially identical to those described in Sec. 3.3. Depth recovery based on experimental data was also topographically achieved (Fig. 4) using the full wide-field optical datasets. In general, for all three techniques, the recovered depth was underestimated by and the resulting images are not homogenous across the entire field. This may be due to several experimental and model-related factors, including edge effects of the inclusion such as seen on the raw fluorescence image in Fig. 1(b). Experimental factors resulting in depth inaccuracies might also include a slight unmixing of intralipid and hemoglobin, possible spatial variations in the light source, stochastic noise propagating into the ratiometric measurements, the intralipid autofluorescence background and the approximations in Eq. (1) that the fluorescence source is point-like and embedded in an infinite, optically homogeneous diffusive medium. Some of these inaccuracies perhaps speak more to the difficulty of creating representative phantoms rather than the validity of the technique. The precision of depth recovery can be improved by (1) maximizing the signal to noise in the single-wavelength fluorescence images and (2) ensuring that the tissue optical properties are known with high accuracy so that Technique 1 can be used. In addition, (3) the spectral shape of nonspecific fluorescent sources is usually known and could be deconvoluted from that associated with the dye of interest in order to minimize the impact of tissue autofluorescence. With the current system, wide-field data acquisition requires for all the fluorescent source depths and tissue optical properties considered (each time, 14 fluorescence images and 14 reflectance images are detected). While this integration time is suboptimal for surgical applications, the critical result shown here is that as few as two fluorescence wavelengths are required for topographic imaging, which should reduce the total imaging to , and potentially much lower when using commercially available faster and more sensitive cameras. Beyond speed and instrument simplicity, one key advantage of this technique is that the ratio of fluorescence intensity at two wavelengths is self-calibrating in that it decouples the molecular information (fluorophore quantum yield, concentration, and lifetime) from the fluorophore spatial localization, as detailed in Ref. 19. This is important because of the difficulty in diffuse tomography to accurately reconstruct and separate optical contrast, spatial localization, and volume. As mentioned in Sec 2.2, the experimental phantom results presented here suggest that the autofluorescence of the bulk medium surrounding the fluorescent inclusion is sufficiently high to prevent detection for depths . However, the actual maximum detectable depth of the proposed technique when using ALA-PpIX for surgical guidance will be subsequently determined in the scope of a clinical study where the technique is used for glioma patients. As previously reported,6,13 the signal-to-background ratio for ALA-PpIX guided brain surgery, at least for high-grade glioma and meningioma, is high enough that the impact of tissue autofluorescence should be negligible. However, for cases where the concentrations of PpIX are much smaller (possibly in the diffusely cancer-infiltrated boundaries of the tumor that are undetectable with the existing technologies), it may be necessary to properly subtract the autofluorescence background from the PpIX signals, and thus increase the maximum detectable depth. A technique using a spectral unmixing algorithm to separate the spectral contribution of autofluorescence from that of the fluorophore of interest is currently being developed by our group. We are also pursuing the use of hyperspectral spatial light modulation imaging18 in order to map the tissue optical properties to retrieve tissue optical properties for every imaging pixel in real time. These optical properties will be used to compute using the analytic expression in Eq. (1)—and retrieve depth using Eq. (7). We and other groups26,27 are also actively investigating fluorophores at longer NIR wavelengths in order to increase the effective depth of subsurface fluorophore detection, so it can be expected that the current depth limit with PpIX can be further improved. However, the requirement for tumor specificity of the fluorescent probe remains and it may be difficult to improve on or even match that of ALA-PpIX. As demonstrated here, an approach to estimating the depth of subsurface fluorescence has been directly implemented on a commercial neurosurgical microscope, making it suitable for clinical application. This is in contradiction to other optical tomography techniques that may be difficult to seamlessly integrate into the neurosurgical workflow because they are relying, e.g., on raster-scanning techniques and are often based on data types extracted from frequency-modulated and time-resolved signals. The simplicity of the proposed approach is that it relies on the acquisition of wide-field continuous-wave images at two different wavelengths. As a result, data acquisition with our technique can be more rapid (compared to other optical tomography techniques) since only two planar fluorescence images are required to provide depth values with minimal data processing time. In fact, the data processing required to obtain pixelized depth values can be almost instantaneous and does not require, e.g., the creation of a finite-elements mesh and the reconstruction of images based on the resolution of an inverse problem. However, the disadvantage of our topography technique is that the resulting depth estimates might be less precise as those that would be obtained using an epi-illumination tomography technique, especially close to the edges of the sources of optical contrast where the use of multiple projections could be required in order to more accurately localize fluorescent objects. It should be noted that providing neurosurgeons with even an approximate depth of tumor lying below the surface of the resection bed is critical to enable maximal safe resection in order to improve patient outcomes, since even small amounts of residual tumor can have a marked impact on the efficacy of adjuvant therapies and consequent survival.7,8 In fact, even the dichotomic information of whether or not the information relating to a source of fluorescence is on the surface or underneath the surface would be of high value to neurosurgeons. AcknowledgmentsThis work was supported by US National Institutes of Health (US) under Grants No. R01NS052274-01A2 and K25 CA164248-01 (CCK) and NSERC (Canada) Discovery Grant Program. ReferencesA. L. Vahrmeijeret al.,
“Image-guided cancer surgery using near-infrared fluorescence,”
Nat. Rev. Clin. Oncol., 10
(9), 507
–518
(2013). http://dx.doi.org/10.1038/nrclinonc.2013.123 NRCOAA 1759-4774 Google Scholar
T. J. Snoekset al.,
“Towards a successful clinical implementation of fluorescence-guided surgery,”
Mol. Imaging Biol., 16
(2), 147
–151
(2014). http://dx.doi.org/10.1007/s11307-013-0707-y 1536-1632 Google Scholar
U. Pichlmeieret al.,
“Resection and survival in glioblastoma multiforme: an RTOG recursive partitioning analysis of ALA study patients,”
Neuro. Oncol., 10
(6), 1025
–1034
(2008). http://dx.doi.org/10.1215/15228517-2008-052 JNODD2 0167-594X Google Scholar
W. Stummeret al.,
“Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial,”
Lancet Oncol., 7
(5), 392
–401
(2006). http://dx.doi.org/10.1016/S1470-2045(06)70665-9 LOANBN 1470-2045 Google Scholar
P. A. Valdeset al.,
“Quantitative, spectrally-resolved intraoperative fluorescence imaging,”
Sci. Rep., 2 798
(2012). http://dx.doi.org/10.1038/srep00798 SRCEC3 2045-2322 Google Scholar
P. A. Valdeset al.,
“Quantitative fluorescence in intracranial tumor: implications for ALA-induced PpIX as an intraoperative biomarker,”
J. Neurosurg., 115
(1), 11
–17
(2011). http://dx.doi.org/10.3171/2011.2.JNS101451 JONSAC 0022-3085 Google Scholar
W. Stummeret al.,
“Prospective cohort study of radiotherapy with concomitant and adjuvant temozolomide chemotherapy for glioblastoma patients with no or minimal residual enhancing tumor load after surgery,”
J. Neurooncol., 108
(1), 89
–97
(2012). http://dx.doi.org/10.1007/s11060-012-0798-3 JNODD2 0167-594X Google Scholar
M. J. McGirtet al.,
“Extent of surgical resection is independently associated with survival in patients with hemispheric infiltrating low-grade gliomas,”
Neurosurgery, 63
(4), 700
–707
(2008). http://dx.doi.org/10.1227/01.NEU.0000325729.41085.73 0148-396X Google Scholar
P. A. Valdeset al.,
“202 5-aminolevulinic acid-induced protoporphyrin IX fluorescence in low-grade gliomas,”
Neurosurgery, 61
(Suppl 1), 227
–228
(2014). http://dx.doi.org/10.1227/01.neu.0000452476.51442.18 0148-396X Google Scholar
P. A. Valdeset al.,
“5-Aminolevulinic acid-induced protoporphyrin IX fluorescence in meningioma: qualitative and quantitative measurements in vivo,”
Neurosurgery, 10
(Suppl 1), 74
–82
(2014). http://dx.doi.org/10.1227/NEU.0000000000000117 0148-396X Google Scholar
D. W. Robertset al.,
“Adjuncts for maximizing resection: 5-aminolevuinic acid,”
Clin. Neurosurg., 59 75
–78
(2012). http://dx.doi.org/10.1227/NEU.0b013e31826b2e8b CLNEA8 0069-4827 Google Scholar
P. A. Valdeset al.,
“A spectrally constrained dual-band normalization technique for protoporphyrin IX quantification in fluorescence-guided surgery,”
Opt. Lett., 37
(11), 1817
–1819
(2012). http://dx.doi.org/10.1364/OL.37.001817 OPLEDP 0146-9592 Google Scholar
P. A. Valdeset al.,
“Combined fluorescence and reflectance spectroscopy for in vivo quantification of cancer biomarkers in low- and high-grade glioma surgery,”
J. Biomed. Opt., 16
(11), 116007
(2011). http://dx.doi.org/10.1117/1.3646916 JBOPFO 1083-3668 Google Scholar
K. Bekeliset al.,
“Quantitative and qualitative 5-aminolevulinic acid-induced protoporphyrin IX fluorescence in skull base meningiomas,”
Neurosurg. Focus, 30
(5), E8
(2011). Google Scholar
A. Kimet al.,
“Quantification of in vivo fluorescence decoupled from the effects of tissue optical properties using fiber-optic spectroscopy measurements,”
J. Biomed. Opt., 15
(6), 067006
(2010). http://dx.doi.org/10.1117/1.3523616 JBOPFO 1083-3668 Google Scholar
A. Kimet al.,
“A fiberoptic reflectance probe with multiple source-collector separations to increase the dynamic range of derived tissue optical absorption and scattering coefficients,”
Opt. Express, 18
(6), 5580
–5594
(2010). http://dx.doi.org/10.1364/OE.18.005580 OPEXFF 1094-4087 Google Scholar
P. A. Valdeset al.,
“System and methods for wide-field quantitative fluorescence imaging during neurosurgery,”
Opt. Lett., 38
(15), 2786
–2788
(2013). http://dx.doi.org/10.1364/OL.38.002786 OPLEDP 0146-9592 Google Scholar
S. D. Koneckyet al.,
“Spatial frequency domain tomography of protoporphyrin IX fluorescence in preclinical glioma models,”
J. Biomed. Opt., 17
(5), 056008
(2012). http://dx.doi.org/10.1117/1.JBO.17.5.056008 JBOPFO 1083-3668 Google Scholar
F. Leblondet al.,
“Analytic expression of fluorescence ratio detection correlates with depth in multi-spectral sub-surface imaging,”
Phys. Med. Biol., 56
(21), 6823
–6837
(2011). http://dx.doi.org/10.1088/0031-9155/56/21/005 PHMBA7 0031-9155 Google Scholar
P. A. Valdeset al.,
“Gadolinium- and 5-aminolevulinic acid-induced protoporphyrin IX levels in human gliomas: an ex vivo quantitative study to correlate protoporphyrin IX levels and blood-brain barrier breakdown,”
J. Neuropathol. Exp. Neurol., 71
(9), 806
–813
(2012). http://dx.doi.org/10.1097/NEN.0b013e31826775a1 JNENAD 0022-3069 Google Scholar
A. Kimet al.,
“Topographic mapping of subsurface fluorescent structures in tissue using multiwavelength excitation,”
J. Biomed. Opt., 15
(6), 066026
(2010). http://dx.doi.org/10.1117/1.3523369 JBOPFO 1083-3668 Google Scholar
W. StummerM. A. Kamp,
“The importance of surgical resection in malignant glioma,”
Curr. Opin. Neurol., 22
(6), 645
–649
(2009). http://dx.doi.org/10.1097/WCO.0b013e3283320165 CONEEX 1350-7540 Google Scholar
M. Lacroixet al.,
“A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival,”
J. Neurosurg., 95
(2), 190
–198
(2001). http://dx.doi.org/10.3171/jns.2001.95.2.0190 JONSAC 0022-3085 Google Scholar
J. S. Smithet al.,
“Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas,”
J. Clin. Oncol., 26
(8), 1338
–1345
(2008). http://dx.doi.org/10.1200/JCO.2007.13.9337 JCONDN 0732-183X Google Scholar
S. Achilefu,
“Introduction to concepts and strategies for molecular imaging,”
Chem. Rev., 110
(5), 2575
–2578
(2010). http://dx.doi.org/10.1021/cr1001113 CHREAY 0009-2665 Google Scholar
S. Achilefu,
“The insatiable quest for near-infrared fluorescent probes for molecular imaging,”
Angew. Chem. Int. Ed. Engl., 49
(51), 9816
–9818
(2010). http://dx.doi.org/10.1002/anie.v49.51 ACIEAY 0570-0833 Google Scholar
X. Zhanget al.,
“Near-infrared molecular probes for in vivo imaging,”
Curr. Protoc. Cytom.,
(2012). Google Scholar
F. Leblondet al.,
“Pre-clinical whole-body fluorescence imaging: review of instruments, methods and applications,”
J. Photochem. Photobiol. B, 98
(1), 77
–94
(2010). http://dx.doi.org/10.1016/j.jphotobiol.2009.11.007 JPPBEG 1011-1344 Google Scholar
K. M. Tichaueret al.,
“Imaging workflow and calibration for CT-guided time-domain fluorescence tomography,”
Biomed. Opt. Express, 2
(11), 3021
–3036
(2011). http://dx.doi.org/10.1364/BOE.2.003021 BOEICL 2156-7085 Google Scholar
R. W. Holtet al.,
“Multiple-gate time domain diffuse fluorescence tomography allows more sparse tissue sampling without compromising image quality,”
Opt. Lett., 37
(13), 2559
–2561
(2012). http://dx.doi.org/10.1364/OL.37.002559 OPLEDP 0146-9592 Google Scholar
A. Laidevantet al.,
“Analytical method for localizing a fluorescent inclusion in a turbid medium,”
Appl. Opt., 46
(11), 2131
–2137
(2007). http://dx.doi.org/10.1364/AO.46.002131 APOPAI 0003-6935 Google Scholar
B. YuanQ. Zhu,
“Separately reconstructing the structural and functional parameters of a fluorescent inclusion embedded in a turbid medium,”
Opt. Express, 14
(16), 7172
–7187
(2006). http://dx.doi.org/10.1364/OE.14.007172 OPEXFF 1094-4087 Google Scholar
D. Hallet al.,
“Simple time-domain optical method for estimating the depth and concentration of a fluorescent inclusion in a turbid medium,”
Opt. Lett., 29
(19), 2258
–2260
(2004). http://dx.doi.org/10.1364/OL.29.002258 OPLEDP 0146-9592 Google Scholar
J. Swartlinget al.,
“Fluorescence spectra provide information on the depth of fluorescent lesions in tissue,”
Appl. Opt., 44
(10), 1934
–1941
(2005). http://dx.doi.org/10.1364/AO.44.001934 APOPAI 0003-6935 Google Scholar
S. L. JacquesB. W. Pogue,
“Tutorial on diffuse light transport,”
J. Biomed. Opt., 13
(4), 041302
(2008). http://dx.doi.org/10.1117/1.2967535 JBOPFO 1083-3668 Google Scholar
A. K. Glaseret al.,
“A GAMOS plug-in for GEANT4 based Monte Carlo simulation of radiation-induced light transport in biological media,”
Biomed. Opt. Express, 4
(5), 741
–759
(2013). http://dx.doi.org/10.1364/BOE.4.000741 BOEICL 2156-7085 Google Scholar
A. Pifferiet al.,
“Performance assessment of photon migration instruments: the MEDPHOT protocol,”
Appl. Opt., 44
(11), 2104
–2114
(2005). http://dx.doi.org/10.1364/AO.44.002104 APOPAI 0003-6935 Google Scholar
|